Author: Scott Welch

Almost 2 million of California’s poorest and most medically fragile residents may have to switch health insurers as a result of a new strategy by the state to improve care in its Medicaid program.

President Joe Biden caused a stir in a “60 Minutes” interview on Sept. 18 when he declared that the covid-19 pandemic is over. “We still have a problem with COVID— we’re still doing a lot of work on it,” Biden said. “But the pandemic is over.”

The American Telehealth Association is working with Congress and several federal agencies to shape the fate of policies and payments for telehealth services that experienced a rapid uptake during the COVID-19 pandemic.

The Texas Medical Association issued a new lawsuit Thursday taking aim at a modified rule implementing a surprise medical bill ban, with the group charging the regulation still unfairly favors insurers.

Overall spending on mental health services increased from 6.8% to 8.2% between 2013 and 2020, according to a new study published by the Employee Benefit Research Institute (EBRI).

America’s prescription-drug prices are out of control. The problem is so large that it has begun attracting high-profile new market entrants, like the Mark Cuban Cost Plus Drug Company that launched earlier this year. Cuban seeks to fix the convoluted prescription-drug market by not taking insurance, and charging 15% over cost. But another path exists for health ...

Employer health startup Transcarent is making its next move with the launch of its new pharmacy program. Transcarent’s Pharmacy Care offering is designed to be fully transparent and integrate with its other platforms. The goal, executives said, is to break through the noise for members and make it easier for them to understand their pharmacy ...

Big tech and retail giants like Amazon and Walmart joined hundreds of provider groups, hospitals and virtual care companies pressing Congress to take action on telehealth legislation this fall. More than 370 organizations sent a joint letter (PDF) to bipartisan leadership of the U.S. Senate to pass a two-year extension of important telehealth policies enacted at the start ...

Consumers are bombarded with misleading advertising for Medicare Advantage and other health plans. Insurance regulators are taking action to identify and combat the improper marketing of these health plans.

The Inflation Reduction Act is set to lower drug prices for millions of people in the U.S. — but experts fear pharmaceutical companies could exploit loopholes in the bill, ultimately keeping prescription costs high for many. The law takes aim at insulin costs, caps out-of-pocket spending for Medicare beneficiaries, and allows the federal government to ...